GoHealth (GOCO) AI Stock Analysis

• Market Cap: $36.61M
• Dividend Yield: N/A
• Average Volume (3M): 54.81K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.76
• Revenue Growth: 7.56%
• EPS Growth: -344.04%
• Country: US
• Employees: 2,261
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Brokers
• EPS (TTM): N/A
• Shares Outstanding: 16,093,117
• 10 Day Avg. Volume: 90,134
• 30 Day Avg. Volume: 54,809
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.73
• Price to Sales (P/S): 0.08
• P/FCF Ratio: -0.21
• Enterprise Value/Market Cap: 1.08
• Enterprise Value/Revenue: 0.11
• Enterprise Value/Gross Profit: 0.14
• Enterprise Value/Ebitda: -0.21
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: $1.50 ▲(9.49% Upside)
• Action: Reiterated Date: 04/01/26
• Date: Action: Reiterated 04/01/26

The score is weighed down primarily by weak financial performance (sharp revenue decline, major losses, and ongoing cash burn) and a bearish technical setup (below key moving averages with negative MACD). Strategy commentary on the earnings call is constructive but constrained by liquidity and volume headwinds, while the Nasdaq noncompliance/delisting risk adds a meaningful negative overhang.

Positive Factors

High gross margins

Sustained gross margins near 78–84% indicate robust unit economics in GoHealth's core distribution model. High gross profitability provides a durable foundation to cover fixed selling and tech costs, enabling margin recovery if the company controls operating expenses and preserves enrollment quality.

Negative Factors

Severe revenue contraction

A 51% annual revenue decline reflects a meaningful loss of scale in the commission-driven model, eroding bargaining power with carriers and absolute earnings potential. Persistent top-line contraction undermines renewal streams and makes fixed-cost absorption harder, pressuring sustainable profitability.

GoHealth Business Overview & Revenue Model

Company Description

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: Medicare—Internal; Medicare—External; Individual and Family Plans (IFP) and Other—Intern...

Read more

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: Medicare—Internal; Medicare—External; Individual and Family Plans (IFP) and Other—Intern...

How the Company Makes Money

GoHealth primarily makes money by acting as a sales and distribution partner for health insurance carriers and earning commissions tied to successful enrollments. The company’s main revenue stream is carrier-paid commissions for Medicare-related e...

Read more

GoHealth primarily makes money by acting as a sales and distribution partner for health insurance carriers and earning commissions tied to successful enrollments. The company’s main revenue stream is carrier-paid commissions for Medicare-related e...

GoHealth Financial Statement Overview

Breakdown	Mar 2026	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	361.85M	798.89M	734.67M	631.67M	1.06B
Gross Profit	291.30M	668.28M	575.71M	444.00M	823.08M
EBITDA	-412.90M	173.71M	24.10M	-211.55M	-393.21M
Net Income	-257.13M	-2.93M	-63.26M	-148.71M	-189.36M
Balance Sheet
Total Assets	987.38M	1.49B	1.50B	1.66B	2.07B
Cash, Cash Equivalents and Short-Term Investments	32.90M	40.92M	90.81M	16.46M	84.36M
Total Debt	35.85M	527.97M	543.05M	557.42M	696.29M
Total Liabilities	949.51M	1.03B	1.04B	1.07B	1.18B
Stockholders Equity	37.87M	294.80M	280.32M	318.06M	353.10M
Cash Flow
Free Cash Flow	-130.19M	-35.34M	95.41M	47.39M	-318.81M
Operating Cash Flow	-121.95M	-21.61M	109.14M	60.90M	-299.01M
Investing Cash Flow	-8.25M	3.81M	-13.73M	-13.51M	-19.80M
Financing Cash Flow	122.00M	-32.03M	-21.11M	-115.05M	259.09M

GoHealth Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.37
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GOCO, the sentiment is Negative. The current price of 1.37 is below the 20-day moving average (MA) of 1.64, below the 50-day MA of 1.77, and below the 200-day MA of 3.69, indicating a bearish trend. The MACD of -0.09 indicates Positive momentum. The RSI at 36.80 is Neutral, neither overbought nor oversold. The STOCH value of 5.64 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GOCO.

GoHealth Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
SLQT	58 Neutral	$106.62M	0.95	13.52%	―	13.16%	―
EHTH	55 Neutral	$39.15M	3.50	4.33%	―	16.79%	―
HUIZ	46 Neutral	$14.43M	2.52	4.56%	―	19.30%	-17.56%
GOCO	43 Neutral	$36.61M	-0.11	-158.66%	―	7.56%	-344.04%

GoHealth Corporate Events